Preventive Vaccine Market Size Share and Industry Outlook to 2028

SKU: DMBT43 | Last Updated On: Dec 16 2021 | No. of Pages: 180 | Available Formats

> Global Preventive Vaccine Market Expected to reach a high CAGR of 13.5% By 2028: DataM Intelligence

Global Preventive Vaccine Market is segmented By Disease Indication (Pneumococcal Disease, DTP, Meningococcal Disease, MMR, Varicella, Influenza, Rotavirus, Polio, Human Papilloma Virus, Hepatitis, Dengue), By End-User (Adults, Pediatrics), By Route of Administration (Oral Administration, Intramuscular and Subcutaneous Administration, Other Routes of Administration), By Technology (Inactivated and Subunit Vaccines, Recombinant Vaccines, Live Attenuated Vaccines, Conjugate Vaccines, Toxoid Vaccines), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2021-2028

 

Market Overview

Global Preventive Vaccine Market Expected to reach a high CAGR of 13.5% By 2028: DataM Intelligence

Why purchase the Preventive Vaccine Market report?

  •  Visualize the composition of the Preventive Vaccine market across each indication, in terms of type and treatment options, highlighting the key commercial assets and players.
  •  Identify commercial opportunities in the Preventive Vaccine market by analyzing trends and co-development deals.
  •  Excel data sheet with thousands of data points of the market- level 4/5 segmentation.
  •  PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  •  Product mapping in excel for key products of all major market players.

Target Audience:

  • Equipment Suppliers/ Buyers
  •  Service Providers/ Buyers
  •  Industry Investors/Investment Bankers
  • Education & Research Institutes
  •  Research Professionals
  •  Emerging Companies
  •  Manufacturers

Trending Topics

Glycomics and Glycobiology Market

Cell Signaling Market

Oncolytic Virus Therapy Market

 

Table of Contents

Chapter 1 –  Preventive Vaccine Market- Methodology and Scope

1.1 Research methodology
1.2 Scope of the Report

Chapter 2 – Preventive Vaccine Market- Headlines & Trends

2.1 Key Trends & Developments

Chapter 3 – Preventive Vaccine Market- Industry Analysis

3.1 Industry Impact Factors (Drivers & Restraints)
3.2 Porter 5 Forces

Chapter 4 – Global Preventive Vaccine Market- product Analysis

4.1 By Disease Indication
4.1.1 Pneumococcal Disease
4.1.2 DTP
4.1.3 Meningococcal Disease
4.1.4 MMR
4.1.5 Varicella
4.1.6 Influenza
4.1.7 Rotavirus
4.1.8 Polio
4.1.9 Human Papilloma Virus
4.1.10 Hepatitis
4.1.11 Dengue
4.2 By End-User
4.2.1 Adults
4.2.2 Pediatrics
4.3 By Route of Administration
4.3.1 Oral Administration
4.3.2 Intramuscular and Subcutaneous Administration
4.3.3 Other Routes of Administration
4.4 By Technology
4.4.1 Inactivated and Subunit Vaccines
4.4.2 Recombinant Vaccines
4.4.3 Live Attenuated Vaccines
4.4.4 Conjugate Vaccines
4.4.5 Toxoid Vaccines

Chapter 5 -Global Preventive Vaccine Market- Geographical Analysis

5.1 Global Preventive Vaccine Market- Geographic Overview
5.2 North America
5.2.1 The USA
5.2.2 Canada
5.2.3 Mexico
5.2.4 Others
5.3 South America
5.3.1 Brazil
5.3.2 Argentina
5.3.3 Others
5.4 Europe
5.4.1 Germany
5.4.2 The United Kingdom
5.4.3 France
5.4.4 Others

Chapter 5 -Global Preventive Vaccine Market- Geographical Analysis

5.5 Asia-Pacific
5.5.1 China
5.5.2 India
5.5.3 Japan
5.5.4 Australia
5.5.5 Others
5.6 Rest of World

Chapter 6- Global Preventive Vaccine Market- Competitive Landscape

6.1 Market Share Analysis
6.2 Key Strategies adopted by Manufacturers
6.3 Product Benchmarking

Chapter 7- Global Preventive Vaccine Market- Company Profiles *

7.1 Astellas Pharma, Inc.
7.2 Astrazeneca
7.3 Bavarian Nordic
7.4 Emergent Biosolutions
7.5 Pfizer, Inc.
7.6 Merck & Co.
7.7 Johnson & Johnson
7.8 Sanofi Pasteur SA
7.9 Mitsubishi Tanabe Pharma Corporation
7.10 GlaxoSmithKline PLC

Chapter 8- Global Preventive Vaccine Market- Appendix

8.1 Sources
8.2 List of Tables
8.3 Expert Panel Validation
8.4 Disclaimer
8.5 Contact Us
*Note: Additional company profiles will be included on client request.

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

20% Discount Applied*



Year-End Offer from
DataM Intelligence

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest